Sees 2023 revenue $61M-$63M, two est. $62.84M.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on IRMD:
- IRADIMED CORPORATION Announces Fourth Quarter and Full Year 2022 Financial Results and Announces Special Cash Dividend
- IRADIMED CORPORATION to Hold 2022 Fourth Quarter Financial Results Conference Call on February 2nd
- IRADIMED CORPORATION Announces Preliminary Financial Results for Fourth Quarter 2022
- iRadimed sees Q1 EPS 26c-28c, one est. 31c
- iRadimed sees 2023 EPS $1.23-$1.34, two est. $1.26